Low E-Health Record Adoption Presents Challenge For R&D Use, AstraZeneca Informatics Scientist Says
Adoption of EHRs “is not where it should be” to make them a valuable part of the drug R&D process, but progress is being made, according to AstraZeneca informatics scientist Sergio Eslava.
You may also be interested in...
The American Society of Clinical Oncology takes the first big step toward a real-time learning network by aggregating data culled from electronic health records, to provide physicians, patients and others with up-to-the-minute evidence on how best to treat cancer.
Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.
The American Association for Cancer Research recommends that meaningful use criteria include a requirement that electronic health records connect to clinical trial databases to encourage greater participation.